Global Cancer Testing & Screening Market Research Report 2024

Report ID: 1993232 | Published Date: Feb 2026 | No. of Page: 87 | Base Year: 2025 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Testing & Screening Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Magnetic Resonance Imaging (MRI)
        1.2.3 Human Papillomavirus (HPV) Testing
        1.2.4 Colonoscopy
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Cancer Testing & Screening Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Lung Cancer
        1.3.3 Blood Cancer
        1.3.4 Bone Cancer
        1.3.5 Gall Bladder Cancer
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cancer Testing & Screening Market Perspective (2017-2028)
    2.2 Cancer Testing & Screening Growth Trends by Region
        2.2.1 Cancer Testing & Screening Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cancer Testing & Screening Historic Market Size by Region (2017-2022)
        2.2.3 Cancer Testing & Screening Forecasted Market Size by Region (2023-2028)
    2.3 Cancer Testing & Screening Market Dynamics
        2.3.1 Cancer Testing & Screening Industry Trends
        2.3.2 Cancer Testing & Screening Market Drivers
        2.3.3 Cancer Testing & Screening Market Challenges
        2.3.4 Cancer Testing & Screening Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cancer Testing & Screening Players by Revenue
        3.1.1 Global Top Cancer Testing & Screening Players by Revenue (2017-2022)
        3.1.2 Global Cancer Testing & Screening Revenue Market Share by Players (2017-2022)
    3.2 Global Cancer Testing & Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cancer Testing & Screening Revenue
    3.4 Global Cancer Testing & Screening Market Concentration Ratio
        3.4.1 Global Cancer Testing & Screening Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Testing & Screening Revenue in 2021
    3.5 Cancer Testing & Screening Key Players Head office and Area Served
    3.6 Key Players Cancer Testing & Screening Product Solution and Service
    3.7 Date of Enter into Cancer Testing & Screening Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Testing & Screening Breakdown Data by Type
    4.1 Global Cancer Testing & Screening Historic Market Size by Type (2017-2022)
    4.2 Global Cancer Testing & Screening Forecasted Market Size by Type (2023-2028)
5 Cancer Testing & Screening Breakdown Data by Application
    5.1 Global Cancer Testing & Screening Historic Market Size by Application (2017-2022)
    5.2 Global Cancer Testing & Screening Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cancer Testing & Screening Market Size (2017-2028)
    6.2 North America Cancer Testing & Screening Market Size by Country (2017-2022)
    6.3 North America Cancer Testing & Screening Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Cancer Testing & Screening Market Size (2017-2028)
    7.2 Europe Cancer Testing & Screening Market Size by Country (2017-2022)
    7.3 Europe Cancer Testing & Screening Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cancer Testing & Screening Market Size (2017-2028)
    8.2 Asia-Pacific Cancer Testing & Screening Market Size by Country (2017-2022)
    8.3 Asia-Pacific Cancer Testing & Screening Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Cancer Testing & Screening Market Size (2017-2028)
    9.2 Latin America Cancer Testing & Screening Market Size by Country (2017-2022)
    9.3 Latin America Cancer Testing & Screening Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cancer Testing & Screening Market Size (2017-2028)
    10.2 Middle East & Africa Cancer Testing & Screening Market Size by Country (2017-2022)
    10.3 Middle East & Africa Cancer Testing & Screening Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Dias Orin
        11.1.1 Dias Orin Company Detail
        11.1.2 Dias Orin Business Overview
        11.1.3 Dias Orin Cancer Testing & Screening Introduction
        11.1.4 Dias Orin Revenue in Cancer Testing & Screening Business (2017-2022)
        11.1.5 Dias Orin Recent Development
    11.2 Epigenetics
        11.2.1 Epigenetics Company Detail
        11.2.2 Epigenetics Business Overview
        11.2.3 Epigenetics Cancer Testing & Screening Introduction
        11.2.4 Epigenetics Revenue in Cancer Testing & Screening Business (2017-2022)
        11.2.5 Epigenetics Recent Development
    11.3 Techlab
        11.3.1 Techlab Company Detail
        11.3.2 Techlab Business Overview
        11.3.3 Techlab Cancer Testing & Screening Introduction
        11.3.4 Techlab Revenue in Cancer Testing & Screening Business (2017-2022)
        11.3.5 Techlab Recent Development
    11.4 Positive Bioscience
        11.4.1 Positive Bioscience Company Detail
        11.4.2 Positive Bioscience Business Overview
        11.4.3 Positive Bioscience Cancer Testing & Screening Introduction
        11.4.4 Positive Bioscience Revenue in Cancer Testing & Screening Business (2017-2022)
        11.4.5 Positive Bioscience Recent Development
    11.5 Genextropy
        11.5.1 Genextropy Company Detail
        11.5.2 Genextropy Business Overview
        11.5.3 Genextropy Cancer Testing & Screening Introduction
        11.5.4 Genextropy Revenue in Cancer Testing & Screening Business (2017-2022)
        11.5.5 Genextropy Recent Development
    11.6 M Genomics
        11.6.1 M Genomics Company Detail
        11.6.2 M Genomics Business Overview
        11.6.3 M Genomics Cancer Testing & Screening Introduction
        11.6.4 M Genomics Revenue in Cancer Testing & Screening Business (2017-2022)
        11.6.5 M Genomics Recent Development
    11.7 20/20 GeneSystems
        11.7.1 20/20 GeneSystems Company Detail
        11.7.2 20/20 GeneSystems Business Overview
        11.7.3 20/20 GeneSystems Cancer Testing & Screening Introduction
        11.7.4 20/20 GeneSystems Revenue in Cancer Testing & Screening Business (2017-2022)
        11.7.5 20/20 GeneSystems Recent Development
    11.8 AB SCIEX
        11.8.1 AB SCIEX Company Detail
        11.8.2 AB SCIEX Business Overview
        11.8.3 AB SCIEX Cancer Testing & Screening Introduction
        11.8.4 AB SCIEX Revenue in Cancer Testing & Screening Business (2017-2022)
        11.8.5 AB SCIEX Recent Development
    11.9 Abbott Laboratories
        11.9.1 Abbott Laboratories Company Detail
        11.9.2 Abbott Laboratories Business Overview
        11.9.3 Abbott Laboratories Cancer Testing & Screening Introduction
        11.9.4 Abbott Laboratories Revenue in Cancer Testing & Screening Business (2017-2022)
        11.9.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Cancer Testing & Screening Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Magnetic Resonance Imaging (MRI)
    Table 3. Key Players of Human Papillomavirus (HPV) Testing
    Table 4. Key Players of Colonoscopy
    Table 5. Key Players of Others
    Table 6. Global Cancer Testing & Screening Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Cancer Testing & Screening Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Cancer Testing & Screening Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Cancer Testing & Screening Market Share by Region (2017-2022)
    Table 10. Global Cancer Testing & Screening Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Cancer Testing & Screening Market Share by Region (2023-2028)
    Table 12. Cancer Testing & Screening Market Trends
    Table 13. Cancer Testing & Screening Market Drivers
    Table 14. Cancer Testing & Screening Market Challenges
    Table 15. Cancer Testing & Screening Market Restraints
    Table 16. Global Cancer Testing & Screening Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Cancer Testing & Screening Market Share by Players (2017-2022)
    Table 18. Global Top Cancer Testing & Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Testing & Screening as of 2021)
    Table 19. Ranking of Global Top Cancer Testing & Screening Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Cancer Testing & Screening Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Cancer Testing & Screening Product Solution and Service
    Table 23. Date of Enter into Cancer Testing & Screening Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cancer Testing & Screening Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Cancer Testing & Screening Revenue Market Share by Type (2017-2022)
    Table 27. Global Cancer Testing & Screening Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Cancer Testing & Screening Revenue Market Share by Type (2023-2028)
    Table 29. Global Cancer Testing & Screening Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Cancer Testing & Screening Revenue Market Share by Application (2017-2022)
    Table 31. Global Cancer Testing & Screening Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Cancer Testing & Screening Revenue Market Share by Application (2023-2028)
    Table 33. North America Cancer Testing & Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Cancer Testing & Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Cancer Testing & Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Cancer Testing & Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Cancer Testing & Screening Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Cancer Testing & Screening Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Cancer Testing & Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Cancer Testing & Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Cancer Testing & Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Cancer Testing & Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Dias Orin Company Detail
    Table 44. Dias Orin Business Overview
    Table 45. Dias Orin Cancer Testing & Screening Product
    Table 46. Dias Orin Revenue in Cancer Testing & Screening Business (2017-2022) & (US$ Million)
    Table 47. Dias Orin Recent Development
    Table 48. Epigenetics Company Detail
    Table 49. Epigenetics Business Overview
    Table 50. Epigenetics Cancer Testing & Screening Product
    Table 51. Epigenetics Revenue in Cancer Testing & Screening Business (2017-2022) & (US$ Million)
    Table 52. Epigenetics Recent Development
    Table 53. Techlab Company Detail
    Table 54. Techlab Business Overview
    Table 55. Techlab Cancer Testing & Screening Product
    Table 56. Techlab Revenue in Cancer Testing & Screening Business (2017-2022) & (US$ Million)
    Table 57. Techlab Recent Development
    Table 58. Positive Bioscience Company Detail
    Table 59. Positive Bioscience Business Overview
    Table 60. Positive Bioscience Cancer Testing & Screening Product
    Table 61. Positive Bioscience Revenue in Cancer Testing & Screening Business (2017-2022) & (US$ Million)
    Table 62. Positive Bioscience Recent Development
    Table 63. Genextropy Company Detail
    Table 64. Genextropy Business Overview
    Table 65. Genextropy Cancer Testing & Screening Product
    Table 66. Genextropy Revenue in Cancer Testing & Screening Business (2017-2022) & (US$ Million)
    Table 67. Genextropy Recent Development
    Table 68. M Genomics Company Detail
    Table 69. M Genomics Business Overview
    Table 70. M Genomics Cancer Testing & Screening Product
    Table 71. M Genomics Revenue in Cancer Testing & Screening Business (2017-2022) & (US$ Million)
    Table 72. M Genomics Recent Development
    Table 73. 20/20 GeneSystems Company Detail
    Table 74. 20/20 GeneSystems Business Overview
    Table 75. 20/20 GeneSystems Cancer Testing & Screening Product
    Table 76. 20/20 GeneSystems Revenue in Cancer Testing & Screening Business (2017-2022) & (US$ Million)
    Table 77. 20/20 GeneSystems Recent Development
    Table 78. AB SCIEX Company Detail
    Table 79. AB SCIEX Business Overview
    Table 80. AB SCIEX Cancer Testing & Screening Product
    Table 81. AB SCIEX Revenue in Cancer Testing & Screening Business (2017-2022) & (US$ Million)
    Table 82. AB SCIEX Recent Development
    Table 83. Abbott Laboratories Company Detail
    Table 84. Abbott Laboratories Business Overview
    Table 85. Abbott Laboratories Cancer Testing & Screening Product
    Table 86. Abbott Laboratories Revenue in Cancer Testing & Screening Business (2017-2022) & (US$ Million)
    Table 87. Abbott Laboratories Recent Development
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Testing & Screening Market Share by Type: 2021 VS 2028
    Figure 2. Magnetic Resonance Imaging (MRI) Features
    Figure 3. Human Papillomavirus (HPV) Testing Features
    Figure 4. Colonoscopy Features
    Figure 5. Others Features
    Figure 6. Global Cancer Testing & Screening Market Share by Application in 2021 & 2028
    Figure 7. Lung Cancer Case Studies
    Figure 8. Blood Cancer Case Studies
    Figure 9. Bone Cancer Case Studies
    Figure 10. Gall Bladder Cancer Case Studies
    Figure 11. Others Case Studies
    Figure 12. Cancer Testing & Screening Report Years Considered
    Figure 13. Global Cancer Testing & Screening Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Cancer Testing & Screening Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Cancer Testing & Screening Market Share by Region: 2021 VS 2028
    Figure 16. Global Cancer Testing & Screening Market Share by Players in 2021
    Figure 17. Global Top Cancer Testing & Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Testing & Screening as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Cancer Testing & Screening Revenue in 2021
    Figure 19. North America Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Cancer Testing & Screening Market Share by Country (2017-2028)
    Figure 21. United States Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Cancer Testing & Screening Market Share by Country (2017-2028)
    Figure 25. Germany Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Cancer Testing & Screening Market Share by Region (2017-2028)
    Figure 33. China Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Cancer Testing & Screening Market Share by Country (2017-2028)
    Figure 41. Mexico Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Cancer Testing & Screening Market Share by Country (2017-2028)
    Figure 45. Turkey Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Cancer Testing & Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Dias Orin Revenue Growth Rate in Cancer Testing & Screening Business (2017-2022)
    Figure 48. Epigenetics Revenue Growth Rate in Cancer Testing & Screening Business (2017-2022)
    Figure 49. Techlab Revenue Growth Rate in Cancer Testing & Screening Business (2017-2022)
    Figure 50. Positive Bioscience Revenue Growth Rate in Cancer Testing & Screening Business (2017-2022)
    Figure 51. Genextropy Revenue Growth Rate in Cancer Testing & Screening Business (2017-2022)
    Figure 52. M Genomics Revenue Growth Rate in Cancer Testing & Screening Business (2017-2022)
    Figure 53. 20/20 GeneSystems Revenue Growth Rate in Cancer Testing & Screening Business (2017-2022)
    Figure 54. AB SCIEX Revenue Growth Rate in Cancer Testing & Screening Business (2017-2022)
    Figure 55. Abbott Laboratories Revenue Growth Rate in Cancer Testing & Screening Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Dias Orin
Epigenetics
Techlab
Positive Bioscience
Genextropy
M Genomics
20/20 GeneSystems
AB SCIEX
Abbott Laboratories
Frequently Asked Questions
Cancer Testing & Screening report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Testing & Screening report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Testing & Screening report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports